| Business Summary | | Dragon
Pharmaceuticals
Inc.
is
a
development
stage
pharmaceutical
and
biotechnological
company
whose
business
plan
is
to
develop,
manufacture
and
market
pharmaceutical
products
in
China.
The
Company
own
a
75%
interest
in
a
drug
manufacturing
company
called
Nanjing
Huaxin
Biotech
Co.
Ltd.
located
in
Nanjing
City,
China
and
is
currently
implementing
its
proprietary
technology
which
will
allow
Nanjing
Huaxin
Biotech
to
produce
drugs
such
as
EPO
in
an
efficient
and
cost-effective
manner.
The
Company's
strategy
is
to
use
its
biotechnological
expertise
to
produce
and
market
pharmaceutical
products
primarily
in
China
at
costs
that
will
be
lower
than
those
currently
available. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Dragon
Pharmaceutical
is
a
development
stage
pharmaceutical
and
biotechnological
company
whose
business
plan
is
to
develop,
manufacture
and
market
pharmaceutical
products
in
China.
For
the
six
months
ended
6/30/01,
sales
decreased
13%
to
$1.3
million.
Net
loss
totaled
$1.8
million,
up
from
$404
thousand.
Revenues
reflect
reduced
sales
of
EPO
in
China.
Loss
also
reflects
increased
production,
administrative,
research
and
new
market
development
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY1999 Pay | |
| Longbin Liu, M.D., 37 Pres,
CEO, Director | $72K | Ken Cai, Ph.D., 35 CFO,
Director | -- | Rita Jervis VP, Devel. | -- | Shaun Maskerine, 32 Sec.,
Treasurer | -- | Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|